RUI: G Protein-Coupled Receptor Kinase 2: Structure and Function
RUI: G Protein-Coupled Receptor Kinase 2: Structure and Function
批准号:
0315888
负责人:
Rachel Sterne-Marr
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-10-01 至 2008-09-30
中文摘要
身体的各个细胞通过激素和神经递质相互交流,这些激素和神经递质是由一个细胞产生的,然后作用于目标细胞。激素或神经递质与特定受体的相互作用在细胞内引发信号级联反应。一种重要的介质是一种叫做G蛋白的分子,它与受体和下游信号分子相互作用,导致特定于细胞类型的反应。例如,当我们感到害怕时,肾上腺素被释放到血液中,它作用于心脏中的目标细胞,导致心率增加。信号的适当强度和持续时间非常重要,因此已经发展出多种机制来调节这种信号。信号调节的一种机制是通过一种叫做G蛋白偶联受体激酶2 (GRK2)的特定蛋白质引起的激素诱导的受体失活。因此,GRK2阻断了肾上腺素启动的信号,使细胞回到基础状态,从而能够适当地对环境做出反应。虽然GRK2最初是通过其调节肾上腺素受体信号传导的能力而被发现的,但现在已知GRK2调节许多受体,称为G蛋白偶联受体,这些受体实际上代表了人类基因组中最大的一类蛋白质。此外,除了改变受体外,GRK2还能结合G蛋白。因此,GRK2“多任务”调节激素信号。该项目的目标是了解GRK2如何执行激素刺激功能,如受体的失活和与G蛋白的相互作用。由于GRK2的形状在原子细节上是已知的,公共数据库和文献可以用来预测,例如,GRK2如何与受体相互作用。下一步是使用分子生物学技术替代单个氨基酸,以评估GRK2的哪些部分对受体相互作用很重要。这些研究不仅将深入了解GRK2对受体的调节机制,而且还将确定这一新蛋白家族的激活机制。确定受体识别位点将最终导致合理设计可能具有治疗价值的GRK2抑制剂。该项目将在一个以本科生为主的机构进行,将允许许多学生参与现代结构、分子和细胞研究。与研究密集型大学的研究人员的广泛合作将确保最新技术的注入,这将反映在这所小型文理学院的细胞生物学、分子生物学和生物化学课程中。首席研究员将保持吸引本科生参与研究(特别是那些来自代表性不足群体的本科生)和培养职业科学家的良好记录。
英文摘要
Individual cells of the body communicate with each other via hormones and neurotransmitters that are produced by one cell and then act on a target cell. The interaction of the hormone or neurotransmitter with a specific receptor sets off a signaling cascade within the cell. An essential mediator is a molecule called a G protein that interacts with both receptor and downstream signaling molecules leading to a response that is specific to the cell type. For example, when we are frightened, adrenalin is released into the bloodstream and it acts on target cells in the heart resulting in an increase in heart-rate. The appropriate intensity and duration of the signal are so important that multiple mechanisms have evolved which modulate such a signal. One mechanism of signal modulation involves hormone-induced inactivation of the receptor by a specific protein called G protein-coupled receptor kinase 2 (GRK2). Thus, GRK2 blocks the signal initiated by adrenalin and allows the cell to return to a basal state so that it can appropriately respond to the environment. Although GRK2 was first identified by its ability to modulate signaling by the adrenalin receptor, it is now known that GRK2 regulates many receptors, called G protein-coupled receptors, and these receptors in fact represent the largest class of proteins in the human genome. Furthermore, in addition to altering the receptor, GRK2 also binds the G protein. Thus, GRK2 "multi-tasks" to regulate hormone signaling. The goal of this project is to understand how GRK2 carries out hormone-stimulated functions such as inactivation of the receptor and interaction with the G protein. Since the shape of GRK2 is known in atomic detail, public databases and the literature can be used to predict, for example, how GRK2 interacts with receptors. The next step is to use molecular biological techniques to substitute individual amino acids to assess which portions of GRK2 are important for receptor interaction. These studies will not only provide insight into the mechanism of receptor regulation by GRK2 but also define a mechanism of activation for this novel family of proteins. Defining receptor recognition sites will ultimately lead to the rational design of GRK2 inhibitors that may have therapeutic value. This project will be carried out at a predominantly undergraduate institution and will allow many students to participate in modern structural, molecular and cellular research. Extensive collaborations with investigators at research-intensive universities will ensure the infusion of the latest technology and this will be reflected in the cell biology, molecular biology and biochemistry curricula at this small liberal arts college. The principal investigator will maintain a strong record of engaging undergraduates in research (especially those from under-represented groups), and producing career scientists.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RUI: G Protein-Coupled Receptor Kinase 2 (GRK2): Mechanism of Activation
-
批准号:0744739
-
项目类别:Continuing Grant
-
资助金额:$60.0万
-
财政年份:2008
-
负责人:Rachel Sterne-Marr
-
依托单位:
RUI: Regulation of Beta-Adrenergic Receptor Kinase
-
批准号:9728179
-
项目类别:Standard Grant
-
资助金额:$18.43万
-
财政年份:1998
-
负责人:Rachel Sterne-Marr
-
依托单位:
国内基金
海外基金
登录
查看更多内容
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对
话促进子宫腺肌病蜕膜化缺陷的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吕海宁
-
依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
-
批准号:32372636
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:郭慧娟
-
依托单位:
抑制Protein Kinase D促进胚胎干细胞自我更新的分子机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:叶守东
-
依托单位:
C2 DOMAIN PROTEIN 1 (C2DP1)基因家族在植物开花调控中的功能研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
凡纳滨对虾Laccase-like protein非酶活依赖参与抗WSSV免疫的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:史黎黎
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
玉米基因Dirigent protein 4的克隆和功能鉴定
-
批准号:32101754
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:秦涛
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
锌指蛋白33B(Zinc finger protein 33B, ZNF33B)抑制乙型脑炎病毒复制的功能与分子机制研究
-
批准号:32072901
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:李祥敏
-
依托单位:
锌指蛋白33B(Zinc finger protein 33B, ZNF33B)抑制乙型脑炎病毒复制的功能与分子机制研究
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2020
-
负责人:李祥敏
-
依托单位: